ENSG vs GEL: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

ENSG is the larger of the two ($10.38B market cap): the incumbent the market prices for continued execution (20.29x forward earnings, beta 0.65). GEL is the smaller challenger ($1.53B), cheaper on forward earnings (16.68x): more room to run, but more to prove. If you believe in growth, ENSG fits: analysts expect its revenue to rise 13% next year, against a 8% decline for GEL. If you believe in paying less for profit, GEL fits: it trades at 16.68x forward earnings, against 20.29x for ENSG.

ENSG vs GEL: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricENSGGELWhat it tells you
Market cap$10.38B$1.53BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E20.2916.68Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E26.4865.84Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.650.77Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range48% of range5% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.

Reading it: GEL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how ENSG and GEL affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ENSG and GEL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ENSG and GEL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does The Ensign Group (ENSG) do?

The Ensign Group runs a network of independently operated skilled nursing facilities, senior living communities, and rehabilitation services across the United States, plus a growing real estate arm (Standard Bearer). As of mid-2026 its subsidiaries operated roughly 398 healthcare operations, including about 48 senior living communities, across 17 states, with a real estate portfolio of roughly 183 properties; in the third quarter it added 22 more operations, including its first in Florida. The business model is to acquire underperforming but strategically located facilities and turn them into profitable local operations, generating revenue mostly from Medicare, Medicaid, and private-insurance reimbursement for short-term rehab and long-term care.

Full ENSG guide

What does Genesis Energy (GEL) do?

Genesis Energy, L.P. (NYSE: GEL) is a diversified midstream energy master limited partnership headquartered in Houston. As an MLP, it is a pass-through entity: investors own limited-partnership units rather than corporate stock, and each year the partnership sends unitholders a Schedule K-1 reporting their share of income, gains, losses, and deductions, instead of the 1099 a normal stock generates. Genesis pays a quarterly cash distribution that is central to the investment case: it declared $0.18 per common unit for the first quarter of 2026 and, on October 8, 2026, declared $0.20 per common unit ($0.80 annualized), payable November 13, about 21% above the year-earlier level. It also has higher-cost Class A Convertible Preferred units (paid $0.9473 per unit for the same quarter) that it has been redeeming to lower its cost of capital.

Full GEL guide

ENSG vs GEL: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • ENSG drivers: Serial-acquisition growth engine; Occupancy and skilled-mix gains.
  • GEL drivers: Offshore Gulf of Mexico volume growth; Shenandoah tie-in and multi-year offshore pipeline.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Ensign derives the majority of its revenue from Medicare and Medicaid, so any cut, freeze, or unfavorable change to government reimbursement rates would pressure margins directly. For GEL, gEL carries commodity and volume exposure: while much of its revenue is fee-based, offshore throughput ultimately depends on producers drilling and completing deepwater wells, and in Q3 2026 producer downtime, Shenandoah well problems and a Salamanca turnaround cut offshore margin about 4%, with management now expecting 2026 adjusted EBITDA near or possibly below the low end of guidance.

ENSG or GEL: which should you pick?

If the story you believe is ENSG's (Serial-acquisition growth engine), ENSG is the more direct way to own it; if it is GEL's (Offshore Gulf of Mexico volume growth), GEL is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ENSG and GEL guides.

ENSG vs GEL: the full fundamentals

ENSG. Ensign trades at a premium to typical healthcare-facility peers on the strength of its consistent double-digit growth; at ~$178 on November 20, 2026 the stock sits about 18% below its 52-week high even though Q3 2026 revenue grew ~14.5% and adjusted EPS beat estimates again. Yahoo's total-debt figure of roughly $2.29 billion includes lease obligations on leased facilities, against about $392 million of cash. The premium multiple assumes the acquisition-led growth continues; consensus for Q4 2026 is about $2.18 EPS on ~$1.60 billion of revenue, and the five-analyst mean target is about $226.

GEL. On trailing GAAP earnings GEL looks expensive (P/E near 66), but MLPs like Genesis are usually valued on distributable cash flow, coverage, EV/EBITDA (about 9.8x here) and yield (about 6.4%). The units sit near the bottom of their 52-week range after the Q3 report confirmed offshore production problems that management expects to last into early 2027, even as marine and onshore results improved and coverage held near 1.6x. Figures are approximate, the K-1 structure affects after-tax returns, and nothing here is investment advice.

Headline figures (approximate, November 2026): ENSG shows revenue (ttm) ~$5.67B, revenue growth (q3 2026, yoy) ~+14.5%, q3 2026 adjusted eps $2.03 vs ~$1.97 est., net income (ttm) ~$399M (~7.0% margin); GEL shows unit price / market cap ~$12.56 close on Nov 20, 2026 (52-week range ~$12.16-18.64); market cap ~$1.5 billion. Down ~21% YTD and ~17% over one year., distribution / yield $0.20 per common unit per quarter ($0.80 annualized); ~6.4% yield at the current price. Q3 2026 coverage ~1.58x on available cash before reserves. Class A preferred paid $0.9473 per unit., revenue (ttm) ~$1.87 billion; latest quarter up ~8.5% year over year per Yahoo Finance. Full-year 2025 revenue was ~$1.63 billion after the soda ash exit., margins / net income Gross margin ~34%, operating margin ~16%, net margin ~4%; trailing net income ~$24 million, EBITDA ~$552 million..

The bottom line: ENSG vs GEL

ENSG and GEL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined ENSG and GEL exposure against your real portfolio. It is not an investment adviser.

Wondering how ENSG or GEL fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about The Ensign Group

Ask Walnut's AI anything about ENSG and see how it fits what you own.

FAQ

What is the difference between ENSG and GEL?

+

The Ensign Group runs a network of independently operated skilled nursing facilities, senior living communities, and rehabilitation services across the United States, plus a growing real estate arm (Standard Bearer). Genesis Energy, L.P. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ENSG or GEL the better stock?

+

Neither is universally better. ENSG is the larger incumbent; GEL is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ENSG or GEL?

+

On forward P/E (as of November 2026), ENSG trades at 20.29x and GEL at 16.68x, so GEL is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ENSG and GEL?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ENSG vs GEL?

+

ENSG: Ensign derives the majority of its revenue from Medicare and Medicaid, so any cut, freeze, or unfavorable change to government reimbursement rates would pressure margins directly. The skilled nursing industry is labor-intensive and exposed to persistent workforce shortages and wage inflation, and proposed federal minimum-staffing mandates could raise costs if reinstated. Growth depends on continuously finding and integrating acquisitions at attractive prices, so a slower pipeline or integration missteps would slow the compounding; the new Florida market brings a busy litigation environment, by management's own account, and revenue growth eased to about 14.5% in Q3 from 17-18% earlier in the year. The stock also trades at a premium valuation, which leaves less cushion if growth decelerates. Finally, the sector carries regulatory, litigation, and quality-of-care compliance risk that can produce fines or reputational damage. The stock's flat performance over the past year, despite steady beats, shows how much of the growth was already in the price at the start of 2026. GEL: GEL carries commodity and volume exposure: while much of its revenue is fee-based, offshore throughput ultimately depends on producers drilling and completing deepwater wells, and in Q3 2026 producer downtime, Shenandoah well problems and a Salamanca turnaround cut offshore margin about 4%, with management now expecting 2026 adjusted EBITDA near or possibly below the low end of guidance. Marine and sulfur results move with refinery activity and shipping demand, and Gulf storms can interrupt both, as Hurricane Isaias did for about four days in early October 2026. Leverage is a real factor; the partnership still carries about $3.1 billion of debt plus about $325 million of preferred units, so rising rates or weaker cash flow could pressure both the balance sheet and the distribution. Earnings have been uneven, with three straight quarterly misses before a Q2 2026 beat and a GAAP loss again in Q3, and analysts expect losses per unit in Q4 2026 and Q1 2027. Distribution sustainability is not guaranteed, as the general partner's board can cut or hold the payout to fund capital projects or deleveraging. Offshore project execution and timing (Shenandoah, tie-ins, third-party wells) can slip. Finally, the MLP structure brings K-1 tax complexity, potential state filings, and unrelated business taxable income (UBTI) considerations in retirement accounts. Not investment advice.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ENSG or GEL; figures are approximate and dated (as of November 2026). Verify current data before investing.